Immune responses to SIV(mne) envelope glycoproteins protect macaques from homologous SIV infection
Por:
hu S.-L., Travis B.M., Stallard V., Abrams K., Misher L., Moran P., Zarling J.M., Langlois A.J., Kuller L., Morton W.R., Benveniste R.E.
Publicada:
1 ene 1992
Resumen:
[No abstract available]
Filiaciones:
hu S.-L.:
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121, United States
Travis B.M.:
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121, United States
Stallard V.:
University of Washington, Seattle, WA, United States
Abrams K.:
University of Washington, Seattle, WA, United States
Misher L.:
University of Washington, Seattle, WA, United States
Moran P.:
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121, United States
Zarling J.M.:
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121, United States
Langlois A.J.:
Duke University Medical Center, Durham, NC, United States
Kuller L.:
University of Washington, Seattle, WA, United States
Morton W.R.:
University of Washington, Seattle, WA, United States
Benveniste R.E.:
National Cancer Institute, Frederick, MD, United States
|